Funded Awards – November 2017

Funded Awards
PI Agency Title
Avraham Beigelman NIH/R01 Admin Supp Azithromycin To Prevent Recurrent Wheezing Following…
F. Sessions Cole PCORI/Children’s Hospital of Philadelphia Automating Quality and Safety Benchmark for Children: …
Allan Doctor DOD/Defense Medical Research and Development Program Novel Artificial Erythrocyte for In-Field Resuscitatio…
Peter Michelson CFF/Cincinnati Children’s Hospital Medical Center A Cystic Fibrosis Collaborative Chronic Care Network C…
Jason Newland NIH/Vanderbilt University Medical Center SCOUTCAP
Philip Spinella NIH/U01 Admin Supp Age of Blood in Children in Pediatric Intensive Care U…
Gregory Storch NIH/University of Alabama DMID -16-0061- An Observational Study Of Acyclovir Pha…
Gregory Storch NIH/University of Alabama DMID 16-0095- A Phase II, Single-Stage, Single-Arm Inv…
Kel Vin Woo American College of Cardiology Endothelial Fibroblast Growth Factor signaling as a po…
Funded Awards
Funded Grants September 2021

PI Agency Title Megan Cooper NIH/ UG3/UH3/Baylor College of Medicine Safety and Efficacy of Itacitinib in treatment of JAK/STAT gain of function disorders Amjad Horani CDI Mechanisms of Primary Ciliary Dyskinesia Cynthia Ortinau Brain & Behavior Research Foundation Association of Parental Psychological Distress with Brain and Neurodevelopment in Congenital Heart …

Funded Awards
Funded Grants August 2021

PI Agency Title Fahd Ahmad NIH/CCHMC EMS for Children: Pediatric Emergency Care Applied Research Network (PECARN)  Jonathan Cooper NIH/R56 Characterizing and testing the efficacy of AAV-mediated gene therapy in a novel CRISPR/Cas9 generated sheepmodel of Cln1 disease. Jorge Di Paola NIH/R01/Ohio State University A Reversible Aptamer Based Therapeutic to Treat …

Funded Awards
Funded Grants July 2021

PI Agency Title Mohamed Abdelbaki EIF/The Hospital for Sick Children 3CI Study: Childhood Cancer Combination Immunotherapy. Phase 1b and Expansion Study of Nivolumab Combination Immunotherapy in Children, Adolescent and Young Adult (CAYA) Patients with Relapsed/Refractory Hypermutant Cancers Amy Armstrong Aflac Foundation/Children’s Healthcare of Atlanta A Maintenance Protocol of Sirolimus in …